文献速递传染病防控与疫情报告卫生政策与健康促进

美国监狱COVID-19变异株暴发的数学建模:疫苗接种与重新开放政策分析

Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies.
PubMed 文献 · Lancet Public Health · 2021-08-06

该研究基于加州州立监狱2020年1月1日至2021年5月15日的居民级数据构建传播动态随机微观模拟模型,评估不同疫苗覆盖率、基线免疫、活动恢复和非药物干预场景下200天内的感染与住院风险。结果显示,在恢复2020年前接触水平、中等疫苗覆盖率且无基线免疫的监狱中,23-74%的居民预期感染;高疫苗覆盖率(90%)联合非药物干预可将累积感染降至2-54%。

要点

  • 恢复2020年前接触水平且无基线免疫时,中等疫苗覆盖率下23-74%居民可能感染。
  • 高疫苗覆盖率(90%)联合非药物干预可将累积感染降至2-54%。
  • 低房间占用率和低累积感染率的监狱中,医疗脆弱人群的住院风险仍很高。

核心结论

  • 在实现高疫苗覆盖率后,以一到二人牢房为主且因既往暴发具有较高基线免疫的监狱,在维持广泛非药物干预、继续检测和保护医疗脆弱人群的前提下,可低风险恢复面对面活动。

研究设计与样本

  • 研究获取加州所有州立监狱2020年1月1日至2021年5月15日的每日居民级数据,包括监狱布局、居住状态、社会人口学和健康特征、活动参与以及COVID-19检测、感染和疫苗接种状态。
  • 开发了以加州数据和已发表文献参数化的传播动态随机微观模拟模型,在初始感染引入监狱后评估各种政策场景对200天内感染和住院的影响。
  • 场景根据疫苗覆盖率、基线免疫(0%、25%或50%)、活动恢复和减少75%传播的非药物干预(NPI)而变化,模拟了五种居住布局和人口特征不同的监狱类型,并估计了200天内有无重复感染引入的结果。

主要发现

  • 若病毒变异株引入已恢复2020年前接触水平、中等疫苗覆盖率(居民36%至76%依年龄而定,工作人员40%)且无基线免疫的监狱,预计200天内23-74%的居民感染。
  • 高疫苗覆盖率(90%)联合NPI可将累积感染降至2-54%。
  • 即使监狱房间占用率低(即不超过两人)且累积感染水平低(即<10%),当这些监狱收容医疗脆弱人群时,住院风险仍然很高。
  • 若重复引入感染,大规模暴发(>20%居民感染)的风险显著更高。

关键数值与推荐

  • 疫苗覆盖率:居民36%至76%(依年龄而定),工作人员40%。
  • 基线免疫:0%、25%或50%。
  • NPI减少传播75%。
  • 高疫苗覆盖率:90%。
  • 大规模暴发定义:>20%居民感染。

临床怎么用

  • 在恢复面对面活动前应实现高疫苗覆盖率(90%),并维持广泛NPI、继续检测和保护医疗脆弱人群。
  • 对于以一到二人牢房为主且具有较高基线免疫的监狱,在高疫苗覆盖率下可低风险恢复活动。
  • 需关注医疗脆弱人群的住院风险,即使房间占用率低和累积感染率低。
  • 重复引入感染会显著增加大规模暴发风险,应持续监测和防控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Residents of prisons have experienced disproportionate COVID-19-related health harms. To control outbreaks, many prisons in the USA restricted in-person activities, which are now resuming even as viral variants proliferate. This study aims to use mathematical modelling to assess the risks and harms of COVID-19 outbreaks in prisons under a range of policies, including resumption of activities. METHODS: We obtained daily resident-level data for all California state prisons from Jan 1, 2020, to May 15, 2021, describing prison layouts, housing status, sociodemographic and health characteristics, participation in activities, and COVID-19 testing, infection, and vaccination status. We developed a transmission-dynamic stochastic microsimulation parameterised by the California data and published literature. After an initial infection is introduced to a prison, the model evaluates the effect of various policy scenarios on infections and hospitalisations over 200 days. Scenarios vary by vaccine coverage, baseline immunity (0%, 25%, or 50%), resumption of activities, and use of non-pharmaceutical interventions (NPIs) that reduce transmission by 75%. We simulated five prison types that differ by residential layout and demographics, and estimated outcomes with and without repeated infection introductions over the 200 days. FINDINGS: If a viral variant is introduced into a prison that has resumed pre-2020 contact levels, has moderate vaccine coverage (ranging from 36% to 76% among residents, dependent on age, with 40% coverage for staff), and has no baseline immunity, 23-74% of residents are expected to be infected over 200 days. High vaccination coverage (90%) coupled with NPIs reduces cumulative infections to 2-54%. Even in prisons with low room occupancies (ie, no more than two occupants) and low levels of cumulative infections (ie, <10%), hospitalisation risks are substantial when these prisons house medically vulnerable populations. Risks of large outbreaks (>20% of residents infected) are substantially higher if infections are repeatedly introduced. INTERPRETATION: Balancing benefits of resuming activities against risks of outbreaks presents challenging trade-offs. After achieving high vaccine coverage, prisons with mostly one-to-two-person cells that have higher baseline immunity from previous outbreaks can resume in-person activities with low risk of a widespread new outbreak, provided they maintain widespread NPIs, continue testing, and take measures to protect the medically vulnerable. FUNDING: Horowitz Family Foundation, National Institute on Drug Abuse, Centers for Disease Control and Prevention, National Science Foundation, Open Society Foundation, Advanced Micro Devices.

来源:Lancet Public Health,查看原文。版权归原作者所有。

引用

  1. Ryckman T, Chin ET, Prince L, et al. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health. 2021. PMID: 34364404. doi:10.1016/S2468-2667(21)00162-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。